PATENT CLAIM ANALYSIS

Application Number: 16242897
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["800", "278000"]

Abstract:
The inventive technology relates to systems and methods for enhanced in vivo production, accumulation and modification of cannabinoids. In one embodiment, the invention may include systems and methods for enhanced in vivo biosynthesis of chemically-modified water-soluble cannabinoids in a whole plant, or a cell suspension culture system.

Claim (Index 173):
The method of  claim 164  wherein said heterologous glycosyltransferase is selected from the group consisting of: the nucleotide sequence identified as SEQ ID NO. 7, the nucleotide sequence identified as SEQ ID NO. 24, the nucleotide sequence identified as SEQ ID NO. 27, the nucleotide sequence identified as SEQ ID NO. 29, the nucleotide sequence identified as SEQ ID NO. 31, the nucleotide sequence identified as SEQ ID NO. 37, and a nucleotide sequence having at least 80% homology to the nucleotide sequence identified as SEQ ID NO. 4, SEQ ID NO. 24, SEQ ID NO. 27, SEQ ID NO. 29 and SEQ ID NO. 37.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 99.0
- Lexical Diversity: 1.40541
- Patent Class: 800.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16110728', '14232465', '14510232', '15321585', '13641272']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6711689063659647
- 35 USC 102 Novelty (BERT): 0.6858782137769136
- Combined Prediction Score: 0.6726398371070597
- Mean Citation Score: 487.126922
- Max Citation Score: 935.623
- Similarity Product: 696.2239862565399

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test